Cargando…

Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers

The aberrant aggregation of proteins is implicated in the onset and pathogenesis of a wide range of neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases. Mounting evidence indicates that misfolded protein oligomers produced as intermediates in the aggregation process are poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kreiser, Ryan P., Wright, Aidan K., Block, Natalie R., Hollows, Jared E., Nguyen, Lam T., LeForte, Kathleen, Mannini, Benedetta, Vendruscolo, Michele, Limbocker, Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696907/ https://www.ncbi.nlm.nih.gov/pubmed/33212787 http://dx.doi.org/10.3390/ijms21228651

Ejemplares similares

Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases
por: Limbocker, Ryan, et al.
Publicado: (2023)

Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
por: Limbocker, Ryan, et al.
Publicado: (2021)

Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity
por: Mannini, Benedetta, et al.
Publicado: (2017)

Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism
por: Limbocker, Ryan, et al.
Publicado: (2020)

Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers
por: Limbocker, Ryan, et al.
Publicado: (2020)

A Brain-Permeable Aminosterol Regulates Cell Membranes to Mitigate the Toxicity of Diverse Pore-Forming Agents
por: Kreiser, Ryan P., et al.
Publicado: (2022)

Distinct responses of human peripheral blood cells to different misfolded protein oligomers
por: Leal‐Lasarte, Magdalena, et al.
Publicado: (2021)

Exogenous misfolded protein oligomers can cross the intestinal barrier and cause a disease phenotype in C. elegans
por: Perni, Michele, et al.
Publicado: (2021)

Membrane Interactions and Toxicity by Misfolded Protein Oligomers
por: Gonzalez-Garcia, Mario, et al.
Publicado: (2021)

Rational design of a conformation-specific antibody for the quantification of Aβ oligomers
por: Aprile, Francesco A., et al.
Publicado: (2020)

Quantitative Measurement of the Affinity of Toxic and Nontoxic Misfolded Protein Oligomers for Lipid Bilayers and of its Modulation by Lipid Composition and Trodusquemine
por: Errico, Silvia, et al.
Publicado: (2021)

Trodusquemine enhances Aβ(42) aggregation but suppresses its toxicity by displacing oligomers from cell membranes
por: Limbocker, Ryan, et al.
Publicado: (2019)

Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
por: Joshi, Priyanka, et al.
Publicado: (2021)

Publisher Correction: Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
por: Joshi, Priyanka, et al.
Publicado: (2021)

Misfolded protein oligomers induce an increase of intracellular Ca(2+) causing an escalation of reactive oxidative species
por: Fani, Giulia, et al.
Publicado: (2022)

Multiplexed Digital Characterization of Misfolded Protein Oligomers via Solid-State Nanopores
por: Sandler, Sarah E., et al.
Publicado: (2023)

Aβ Oligomers Dysregulate Calcium Homeostasis by Mechanosensitive Activation of AMPA and NMDA Receptors
por: Fani, Giulia, et al.
Publicado: (2021)

A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells
por: Zampagni, Mariagioia, et al.
Publicado: (2011)

A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease
por: Ikenoue, Tatsuya, et al.
Publicado: (2020)

Lipid Homeostasis and Its Links With Protein Misfolding Diseases
por: Vendruscolo, Michele
Publicado: (2022)

The elusive nature and diagnostics of misfolded Aβ oligomers
por: Cerasoli, Eleonora, et al.
Publicado: (2015)

A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

Publisher Correction: A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)
por: Mroczko, Barbara, et al.
Publicado: (2019)

The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
por: Xu, Catherine K., et al.
Publicado: (2022)

SAR by kinetics for drug discovery in protein misfolding diseases
por: Chia, Sean, et al.
Publicado: (2018)

Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease
por: Tai, Hwan-Ching, et al.
Publicado: (2014)

Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease
por: Heller, Gabriella T., et al.
Publicado: (2020)

Combinations of Vitamin A and Vitamin E Metabolites Confer Resilience against Amyloid-β Aggregation
por: Joshi, Priyanka, et al.
Publicado: (2023)

Single molecule secondary structure determination of proteins through infrared absorption nanospectroscopy
por: Ruggeri, Francesco Simone, et al.
Publicado: (2020)

The molecular chaperone Brichos breaks the catalytic cycle that generates toxic Aβ oligomers
por: Cohen, Samuel I. A., et al.
Publicado: (2015)

Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
por: Ghadami, Seyyed Abolghasem, et al.
Publicado: (2020)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
por: Gerson, Julia E., et al.
Publicado: (2018)

Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas
por: Bhowmick, Diti Chatterjee, et al.
Publicado: (2022)

The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012)

X-ray Crystallographic Structure of Oligomers Formed by a Toxic β-Hairpin Derived from α-Synuclein: Trimers and Higher-Order Oligomers
por: Salveson, Patrick J., et al.
Publicado: (2016)

Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases
por: Evangelisti, Elisa, et al.
Publicado: (2016)

Delivery of Native Proteins into C. elegans Using a Transduction Protocol Based on Lipid Vesicles
por: Perni, Michele, et al.
Publicado: (2017)

Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC
por: Palazzi, Luana, et al.
Publicado: (2021)

The Toxicity and Polymorphism of β-Amyloid Oligomers
por: Huang, Ya-ru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ho7u81pnhnhjnsdd8nc2e5puaq